Literature DB >> 15196766

A host/plasmid system that is not dependent on antibiotics and antibiotic resistance genes for stable plasmid maintenance in Escherichia coli.

Peter Hägg1, Johanna Wa de Pohl, Farhad Abdulkarim, Leif A Isaksson.   

Abstract

Uneven distribution of plasmid-based expression vectors to daughter cells during bacterial cell division results in an increasing proportion of plasmid free cells during growth. This is a major industrial problem leading to reduction of product yields and increased production costs during large-scale cultivation of vector-carrying bacteria. For this reason, a selection must be provided that kills the plasmid free cells. The most conventional method to obtain this desired selection is to insert some gene for antibiotic resistance in the plasmid and then grow the bacteria in the presence of the corresponding antibiotic. We describe here a host/plasmid Escherichia coli system with a totally stable plasmid that can be maintained without the use of antibiotic selection. The plasmid is maintained, since it carries the small essential gene infA (coding for translation initiation factor 1, IF1) in an E. coli strain that has been deleted for its chromosomal infA gene. As a result only plasmid carrying cells can grow, making the strain totally dependent on the maintenance of the plasmid. A selection based on antibiotics is thus not necessary during cultivation, and no antibiotic-resistance genes are present neither in the final strain nor in the final plasmid. Plasmid-free cells do not accumulate even after an extended period of continuous growth. Growth rates of the control and the plasmid harboring strains are indistinguishable from each other in both LB and defined media. The indicated approach can be used to modify existing production strains and plasmids to the described concept. The infA based plasmid stability system should eliminate industrial cultivation problems caused by the loss of expression vector and use of antibiotics in the cultivation medium. Also environmental problems caused by release of antibiotics and antibiotic resistance genes, that potentially can give horizontal gene transfer between bacterial populations, are eliminated.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15196766     DOI: 10.1016/j.jbiotec.2004.03.010

Source DB:  PubMed          Journal:  J Biotechnol        ISSN: 0168-1656            Impact factor:   3.307


  23 in total

Review 1.  Rational vector design for efficient non-viral gene delivery: challenges facing the use of plasmid DNA.

Authors:  Juergen Mairhofer; Reingard Grabherr
Journal:  Mol Biotechnol       Date:  2008-06       Impact factor: 2.695

2.  Generation of a Stable Plasmid for In Vitro and In Vivo Studies of Staphylococcus Species.

Authors:  Christina N Krute; Kelsey L Krausz; Mary A Markiewicz; Jason A Joyner; Srijana Pokhrel; Pamela R Hall; Jeffrey L Bose
Journal:  Appl Environ Microbiol       Date:  2016-09-16       Impact factor: 4.792

Review 3.  New generation of plasmid backbones devoid of antibiotic resistance marker for gene therapy trials.

Authors:  Gaëlle Vandermeulen; Corinne Marie; Daniel Scherman; Véronique Préat
Journal:  Mol Ther       Date:  2011-08-30       Impact factor: 11.454

Review 4.  New technologies in developing recombinant attenuated Salmonella vaccine vectors.

Authors:  Shifeng Wang; Qingke Kong; Roy Curtiss
Journal:  Microb Pathog       Date:  2012-11-08       Impact factor: 3.738

5.  Novel antibiotic-free plasmid selection system based on complementation of host auxotrophy in the NAD de novo synthesis pathway.

Authors:  Wei-Ren Dong; Li-Xin Xiang; Jian-Zhong Shao
Journal:  Appl Environ Microbiol       Date:  2010-01-29       Impact factor: 4.792

6.  Designing an Escherichia coli Strain for Phenylalanine Overproduction by Metabolic Engineering.

Authors:  Neetu Tyagi; Deepti Saini; Richa Guleria; Krishna Jyoti Mukherjee
Journal:  Mol Biotechnol       Date:  2017-05       Impact factor: 2.695

7.  Production of extracellular fatty acid using engineered Escherichia coli.

Authors:  Hui Liu; Chao Yu; Dexin Feng; Tao Cheng; Xin Meng; Wei Liu; Huibin Zou; Mo Xian
Journal:  Microb Cell Fact       Date:  2012-04-03       Impact factor: 5.328

8.  Antibiotic-free selection in E. coli: new considerations for optimal design and improved production.

Authors:  Isabelle Peubez; Nicolas Chaudet; Charlotte Mignon; Géraldine Hild; Stéphanie Husson; Virginie Courtois; Karelle De Luca; Denis Speck; Régis Sodoyer
Journal:  Microb Cell Fact       Date:  2010-09-07       Impact factor: 5.328

9.  Factors affecting plasmid production in Escherichia coli from a resource allocation standpoint.

Authors:  Drew S Cunningham; Richard R Koepsel; Mohammad M Ataai; Michael M Domach
Journal:  Microb Cell Fact       Date:  2009-05-22       Impact factor: 5.328

10.  A comparison of immunogenicity and protective immunity against experimental plague by intranasal and/or combined with oral immunization of mice with attenuated Salmonella serovar Typhimurium expressing secreted Yersinia pestis F1 and V antigen.

Authors:  Wen-Tssann Liu; Hui-Ling Hsu; Chung-Chih Liang; Chuan-Chang Chuang; Huang-Chi Lin; Yu-Tien Liu
Journal:  FEMS Immunol Med Microbiol       Date:  2007-07-19
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.